Impact of family socioeconomic position on childhood asthma outcomes, severity, and specialist referral – a Danish nationwide study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,42 MB, PDF-dokument

Background
Asthma is the most common chronic illness in children, carrying a major burden. Socioeconomic position (SEP) affects adult asthma outcomes, but its impact on childhood asthma, particularly in primary versus specialist care, has not been studied thoroughly.
Methods
In a Danish cohort consisting of all children aged 2–17 years redeeming inhaled corticosteroids in 2015, parental SEP impact on asthma outcomes was investigated. Workforce attachment, income, education, and metropolitan residence were chosen as covariates in logistic regression. Outcomes were uncontrolled (excessive use of short-acting beta2-agonists), exacerbating (oral corticosteroid use or hospitalization), and severe asthma (according to GINA 2020).
Results
The cohort comprised 29,851 children (median age 8.0, 59% boys). 16% had uncontrolled asthma, 8% had ≥1 exacerbation. Lower income and metropolitan residence correlated with higher odds of poor control, exacerbations, and severe asthma. Lower education correlated with worse asthma outcomes. Education and income were protective factors in primary care, but not in specialist care. Metropolitan residence was the sole factor linked to specialist care referral for severe asthma.
Conclusion
Low parental SEP and metropolitan residence associated with poor asthma outcomes. However, specialist care often mitigated these effects, though such care was less likely for at-risk children in non-metropolitan areas.
OriginalsprogEngelsk
TidsskriftChronic Respiratory Disease
Vol/bind21
Antal sider10
ISSN1479-9723
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The present work was funded by the Børnelungefonden, Trial Nation Denmark Respiratory, Respiratory Research Unit, Hvidovre Hospital, and SanofiGenzyme. All grants were unrestricted research grants, and grantors were not involved in any aspects pertinent to planning, conducting, analysing, or presenting the present study results.

Publisher Copyright:
© The Author(s) 2024.

ID: 386414413